| Tag | Content |
|---|
EnhancerAtlas ID | HS193-17870 |
Organism | Homo sapiens |
Tissue/cell | U87 |
Coordinate | chr2:61872890-61873950 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| FOSL1 | MA0477.1 | chr2:61873658-61873669 | GGTGACTCATG | + | 6.62 | | JUND | MA0491.1 | chr2:61873658-61873669 | GGTGACTCATG | + | 6.02 | | MEF2C | MA0497.1 | chr2:61873280-61873295 | AAGTTAAAAATAGAA | + | 6.55 | | SOX10 | MA0442.2 | chr2:61873157-61873168 | AAAACAAAGCA | + | 6.02 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH02I061645 | chr2 | 61872581 | 61874553 |
|
Enhancer Sequence | TTGCACTCCA GCCTGAGCAC CACAGTGAGA CCTTGTCTCA AAATAAATAA AATAAAATAA 60
AATAAATAAA AATGGGCAAA GTTATTTTAT ATCTTTTGTG GGTGAAAAAA ATGGGCAAAG 120
GATTTGAATA GATATTTTTC CAGAAAAAGT ATACAAATGG CCAAAAAGCA CTTGAAAAGA 180
TGTTCAACAT TATTAGTCAC TAGGCAAGTG CAAACCAAAA CCACAATGAC GAGGTACCAC 240
TTCATACCAA TAGGATGACT ATAATTTAAA ACAAAGCAAA ATGAAATGAA AATTTACAAA 300
TGTTGGTGAG GATGTGGAAA AGATGGAACT TTTGTACATT GCTTGTACAA AAGTACAAGA 360
AATATAAAAT GGCACAGCCA GTTCCTCAAA AAGTTAAAAA TAGAATTACC ATATGACCCA 420
GCAGTTCCAC TCCTGGTATA CACCCCAAAG TATTGAAAAC AGCTGTCCAA GCAAAAACTT 480
ACAGATGAAT ATTTATAGCA GCACCATCCA CAATAGCCAA AAGGTGGAAA CAACCCAAAT 540
GTAAAGTATC TAATGAACGG GTAAATAAAA TGTGGTGTGT GACACACATA CACACACACA 600
CACACACACA CACATAATGG GATGTTATTC TGCCATAAAA GGAATGAAGT ACTAATGCAT 660
ACTACAACAT GGATAAACCT TGAAAACATT ATGCTAAGTG AAAGCGACCA GACACAAAAG 720
GCCACATATT ATATGATTCC ACTTATATAA AATACCCAAA TTGTGTGTGG TGACTCATGC 780
CTGTAATCCC AGCAATCTGG GAGGCCAAGG CAGGAGGATC ACTTGAGCCT AGGAGTTCAA 840
GACCAGCCTG GGCAACATGG CAAACCCCTG TCTCTACAAA AAAATAGAAA ACATTAGCTA 900
TGGTAGCATG TACCTGTAGT CCCAGCTTCT TGGGAGGCTG AGGTGGGAGA ATCACCGGAG 960
CCCAGGAAGT CGAGGCTGCA GTGAGCCATG ATTGCACCAC TGTAGTCCAG CCTGGGTGAC 1020
AGAGTGAGAC TCTGTCTCAA TAAATAAATA AATAAATAAA 1060
|
